Cases & Deals

IntegraGen’s shareholders sell majority interest to OncoDNA in tender offer

Client(s) IntegraGen

Jones Day advised IntegraGen, a biotechnology company developing molecular markers for central nervous system and metabolic diseases, in connection with the public tender offer of shares by OncoDNA, a private health technology and precision medicine company focused on oncology.